Matthew Davids, MD, MMSc
drmdavids.bsky.social
Hematologist/oncologist, translational CLL investigator, director of lymphoma clinical research @dana-farber, faculty @harvard med. posts are my own & not medical advice
👤 Joined on 03 March 2025
89
Followers
69
Following
3
Total Posts
📜 Kullanıcı Geçmişi
- 03 Mar 2025, 14:14
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@drmdavids.bsky.social
🚫 Blokladığı Kullanıcılar
Bu kullanıcının blokladığı kullanıcı bulunamadı.
❤️ Beğendiği Gönderiler
It was great to catch up with @drmdavids.bsky.social of @danafarber.bsky.social at #iwCLL2025!🎥 Hear as Dr Davids introduces the MAVRiC trial, which will investigate a mutation-guided retreatment strategy using the AV regimen in patients with CLL/SLL in the 2L setting: 👉 buff.ly/aouDK9h #CLLsm
Show Post